Vistara
1 known investors
VistaraBio provides research tools and services for drug discovery, including modified protein assays, post-translationally modified protein catalogs, and cell screening platforms using bioactive peptides. The company serves pharmaceutical and biotech researchers developing small molecule and protein degrader therapeutics.
BiotechDeep Tech
Investors · 1
In the news
- Vistara Growth Announces Final Close of Fund V at US$321Mvistaragrowth.com · 2025
- Vistara Growth closes $321-million USD fund after “friend-raising to the max” | BetaKitbetakit.com · 2025
- Vistara Growth Tracking Toward September 30 Final Close With Over US$265 Million Raised to Datebusinesswire.com · 2025
- Algo Raises $20 Million Funding From Vistara Growth To Accelerate Global Expansion and AI Solution Delivery | Vistara Growthvistaragrowth.com · 2024
- Vistara raises initial $150m-plus for fifth software growth fundventurecapitaljournal.com · 2023
- Vistara Growth - 2026 Investor Profile, Portfolio & Team - Tracxntracxn.com · 2021